Rosuvastatin: An Effective Lipid Lowering Drug against Hypercholesterolemia
The Internet Journal of Cardiovascular Research · 2006
DOI: 10.5580/22bb ↗At a glance
Journal article in The Internet Journal of Cardiovascular Research, 2006.
Abstract (original language)
Hypercholesterolemia (HC) is primarily implicated in the progression of coronary heart disease (CHD) and its treatment is essential. Statin such as rosuvastatin, the lipid-lowering agent, is well known for its ability to normalize patient's serum cholesterol level. The study was designed, to compare the lipid-modifying efficacy of rosuvastatin across HC. The efficacy of rosuvastatin (10mg) was found in 162 patients who met the inclusion criteria [fasting Total cholesterol (TC) concentration ≥ 200mg/dl, low density lipoprotein-Cholesterol (LDL-C) ≥ 130mg/dl and triglyceride (TG) ≤ 300 mg/dl]. Selected patients were subdivided into two groups (group 1 TC ≤ 240 mg/dl and group 2 TC > 240 mg/dl). The efficacy was determined by measuring changes from baseline in lipid parameters including LDL-C, TC, TG, high density lipoprotein-Cholesterol (HDL-C) and non-high density lipoprotein-Cholesterol (NHDL-C). TC, LDL-C, and NHDL-C significantly (p
Cite
APA
(2006). Rosuvastatin: An Effective Lipid Lowering Drug against Hypercholesterolemia. The Internet Journal of Cardiovascular Research. https://doi.org/10.5580/22bb
Vancouver
Rosuvastatin: An Effective Lipid Lowering Drug against Hypercholesterolemia. The Internet Journal of Cardiovascular Research. 2006. doi:10.5580/22bb
BibTeX
@article{euvimed2006,
title = {Rosuvastatin: An Effective Lipid Lowering Drug against Hypercholesterolemia},
journal = {The Internet Journal of Cardiovascular Research},
year = {2006},
doi = {10.5580/22bb}
}
EUVIMED